Sarah L Mackie

Sarah L Mackie

UNVERIFIED PROFILE

Are you Sarah L Mackie?   Register this Author

Register author
Sarah L Mackie

Sarah L Mackie

Publications by authors named "Sarah L Mackie"

Are you Sarah L Mackie?   Register this Author

40Publications

1216Reads

21Profile Views

Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group.

J Rheumatol 2019 Oct 1;46(10):1360-1364. Epub 2019 Feb 1.

From the Department of Rheumatology, Austin Health; Department of Medicine, University of Melbourne, Melbourne; Rheumatology Unit, Royal Adelaide Hospital; Discipline of Medicine, The University of Adelaide, Adelaide, Australia; Department of Rheumatology, Addenbrooke's Hospital, Cambridge; Norwich Medical School, University of East Anglia, Norwich; Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele; PMR-GCA Scotland, Dundee, Angus; PMR-GCA North East, Kibblesworth, Tyne and Wear; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR)-Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, UK; Ottawa Hospital Research Institute; School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Ontario, Canada; SDG LLC, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181050DOI Listing
October 2019

Characteristics of patients with giant cell arteritis who experience visual symptoms.

Rheumatol Int 2019 Oct 22;39(10):1789-1796. Epub 2019 Aug 22.

School of Primary, Community and Social Care, Keele University, David Weatherall Building, Keele, ST5 5BG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-019-04422-5DOI Listing
October 2019

Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group.

J Rheumatol 2019 Sep 15;46(9):1179-1182. Epub 2019 Jan 15.

From the Division of Rheumatology, Hospital for Special Surgery; Department of Medicine, and the Division of General Internal Medicine, Weill Cornell Medicine, New York; Department of Social Work, Binghamton University, Binghamton, New York; SDG LLC, Cambridge, Massachusetts, USA; Rheumatology Unit, Royal Adelaide Hospital; Discipline of Medicine, The University of Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia; Faculty of Health and Applied Science, University of the West of England; School of Clinical Science, University of Bristol, Bristol; Leeds Biomedical Research Centre, Leeds Institute of Rheumatic and Musculoskeletal Medicine; Chapel Allerton Hospital, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629524PMC
September 2019

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

J Rheumatol 2019 Aug 15;46(8):1053-1058. Epub 2019 Jan 15.

From the Department of Family Medicine, and Department of Medicine, McGill University, Montreal, Quebec; Institute for Work & Health, Toronto; OMERACT; Ottawa Hospital Research Institute, Ottawa Hospital; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Division of Rheumatology, Hospital for Special Surgery; Department of Medicine, Weill Cornell Medical School, New York, New York; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona; Medicine Service, VA Medical Center; Department of Medicine, School of Medicine, University of Alabama at Birmingham; Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California; SDG LLC, Cambridge, Massachusetts, USA; Sydney Medical School, and Sydney School of Public Health, University of Sydney; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District; Department of Rheumatology, Royal North Shore Hospital, Reserve Road, St Leonards; Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Melbourne; Discipline of Medicine, University of Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville; Department of Rheumatology, Royal Prince Alfred Hospital, Camperdown, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust; NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, France; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181123DOI Listing
August 2019

Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study.

Rheumatology (Oxford) 2019 Jul 19. Epub 2019 Jul 19.

Centre for Epidemiology Versus Arthritis, Norwich Medical School, University of East Anglia, Norwich, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez289DOI Listing
July 2019

A probability score to aid the diagnosis of suspected giant cell arteritis.

Clin Exp Rheumatol 2019 Mar-Apr;37 Suppl 117(2):104-108. Epub 2019 Feb 15.

Southend University Hospital NHS Trust, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.

View Article

Download full-text PDF

Source
June 2019

Comparative effectiveness of F-FDG PET-CT and contrast-enhanced CT in the diagnosis of suspected large-vessel vasculitis.

Br J Radiol 2018 Sep 5;91(1089):20180247. Epub 2018 Jul 5.

1 Department of Radiology and Nuclear Medicine, St James's University Hospital , Leeds , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20180247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223176PMC
September 2018

Preliminary concurrent validity of the Fitbit-Zip and ActiGraph activity monitors for measuring steps in people with polymyalgia rheumatica.

Gait Posture 2018 03 31;61:339-345. Epub 2018 Jan 31.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, LS7 4SA, United Kingdom; School of Human and Health Sciences, University of Huddersfield, Huddersfield, HD1 3DH, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gaitpost.2018.01.035DOI Listing
March 2018

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.

J Rheumatol 2017 Dec 15;44(12):1904-1910. Epub 2016 Dec 15.

From the Department of Nursing and Midwifery, University of the West of England; University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds; Department of Rheumatology, Ashford and St. Peter's National Health Service (NHS) Foundation Trust, Chertsey; Patient Research Partner PMR-GCA Scotland, Forest Lodge, Foulden, Berwickshire, UK; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District; Department of Rheumatology, Royal North Shore Hospital, New South Wales; University of Sydney, Sydney; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide; Discipline of Medicine, University of Adelaide, Adelaide, Australia; Division of Clinical Epidemiology, Division of Rheumatology, and Division Respiratory Epidemiology, McGill University/McGill University Health Centers, Montreal, Québec; Patient Research Partner, Toronto Western Hospital, Toronto; Cochrane Musculoskeletal Group, Institute of Population Health, Ottawa, Ontario, Canada; Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, Maryland; University of Illinois-Chicago, Chicago, Illinois; Healthy Motivation and Global Alliance for Musculoskeletal Health the Bone and Joint Decade, Santa Barbara, California, USA; Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany; Horizon Pharma LTD, Dublin, Ireland; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161073DOI Listing
December 2017

A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group.

J Rheumatol 2017 Nov 1;44(11):1754-1758. Epub 2017 Apr 1.

From the Discipline of Medicine, School of Public Health, The University of Adelaide; Rheumatology Unit, The Royal Adelaide Hospital, Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia; Faculty of Health and Applied Sciences, University of the West of England; University of Bristol, Bristol; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; PMR & GCA UK North East, Kibblesworth; PMR and GCA Scotland, Berwickshire, Foulden, UK; Hospital for Special Surgery, New York, New York; SDG LLC, Cambridge, Massachusetts; Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, Pennsylvania, USA; F. Hoffmann-Roche Ltd., Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161083DOI Listing
November 2017

Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.

BMJ Case Rep 2017 Nov 8;2017. Epub 2017 Nov 8.

NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2017-221065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695391PMC
November 2017

The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.

J Rheumatol 2017 Oct 1;44(10):1515-1521. Epub 2017 Aug 1.

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, and UK National Institute for Health Research (NIHR), Leeds; Academic Unit of Primary Medical Care, University of Sheffield, Sheffield; PMR-GCA Scotland, Dundee; PMR-GCA North East, Gateshead; Primary Care and Health Sciences, Keele University, Keele; Norfolk and Norwich University Hospital, Norwich, UK; Ottawa Hospital Research Institute and School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Ontario, Canada; Discipline of Medicine, The University of Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia; Division of Rheumatology, University of California Los Angeles (UCLA), Los Angeles, California; Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; SDG LLC, Cambridge, Massachusetts, USA; Department of Rheumatology and Clinical Immunology, Charite University Hospital Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690488PMC
October 2017

What is the impact of giant cell arteritis on patients' lives? A UK qualitative study.

BMJ Open 2017 Aug 23;7(8):e017073. Epub 2017 Aug 23.

Research Institute for Primary Care and Health Sciences, Keele University, Keele, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2017-017073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724062PMC
August 2017

Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis.

BMC Med 2017 06 28;15(1):120. Epub 2017 Jun 28.

Research Institute for Primary Care and Health Sciences, Keele University, ST5 5BG, Newcastle, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-017-0871-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488376PMC
June 2017

Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.

Rheumatology (Oxford) 2016 Dec 16;55(12):2181-2190. Epub 2016 Sep 16.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds & NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew306DOI Listing
December 2016

Response to: 'A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?' by Yang et al.

Ann Rheum Dis 2016 Apr 27;75(4):e17. Epub 2016 Jan 27.

University of Leeds. Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2015-208962DOI Listing
April 2016

Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis.

Medicine (Baltimore) 2016 Feb;95(8):e2368

From the Vasculitis Research Unit, Department of Autoimmune Diseases (JHR, GM, IV, CF, SPG, GEF, MCC); Department of Anatomic Pathology, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (EC); Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust (SLM, EMAH, AWM); Leeds Teaching Hospitals NHS Trust, Leeds, UK (AC); Department of Internal Medicine, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (JMG).

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/md-journal/2016/02230/Descripti
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000002368DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778989PMC
February 2016

Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.

J Rheumatol 2016 Jan 15;43(1):182-6. Epub 2015 Nov 15.

From the Department of Primary Care Sciences, Keele University, Staffordshire, UK; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center, Groningen, The Netherlands; Department of Rheumatology, Leeds Teaching Hospitals ( UK) National Health Service (NHS) Trust, Leeds, UK; Department of Rheumatology Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, Surrey, UK; Rheumatology Unit, The Queen Elizabeth Hospital, University of Adelaide, Woodville, South Australia; PMR-GCA Scotland, Forest Lodge, Foulden, Berwickshire, UK; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; SDC LLC, Cambridge, Massachusetts, USA; Department of Primary Care Sciences, Keele University, Staffordshire, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; UK National Institute for Health Research (NIHR)-Leeds Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.T. Helliwell, MRCGP, MMedSci, Department of Primary Care Sciences, Keele University; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center; C.T. Pease, MD, FRCP, Department of Rheumatology, Leeds Teaching Hospitals NHS Trust; R. Hughes, MA, MD, FRCP, Department of Rheumatology Ashford and St. Peter's Hospitals NHS Foundation Trust; C.L. Hill, MBBS, MD, MSc, FRACP, Staff Specialist, Rheumatology Unit, Queen Elizabeth Hospital, University of Adelaide; L.M. Neill, BSc, CPhys, MInstP, Trustee and Secretary, PMR-GCA Scotland; S. Halls, MSc, BSc, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; L.S. Simon, MD, SDC LLC; C.D. Mallen, BMBS, PhD, FRCGP, Department of Primary Care Sciences, Keele University;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141179DOI Listing
January 2016

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

J Rheumatol 2015 Dec 15;42(12):2465-9. Epub 2015 Jun 15.

From the Division of Rheumatology, Koc University Faculty of Medicine, Istanbul; Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey; Division of Rheumatology, and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, Istanbul University Istanbul Faculty of Medicine; Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey; Division of Rheumatology, University of California, Los Angeles, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Department of Internal Medicine, University Paris Diderot, Paris, France; Division of Rheumatology, Ohio State University, Columbus, Ohio, USA; Division of Rheumatology, University of Ottawa, Ottawa, Ontario, Canada; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland.S.Z. Aydin, MD, Associate Professor, Division of Rheumatology, Koc University Faculty of Medicine; H. Direskeneli, MD, Professor of Rheumatology, Division of Rheumatology, Marmara University Faculty of Medicine; A. Sreih, MD, Assistant Professor of Medicine, Division of Rheumatology, University of Pennsylvania; F. Alibaz-Oner, MD, Division of Rheumatology, Marmara University Faculty of Medicine; A. Gul, Professor, Division of Rheumatology, Istanbul University Istanbul Faculty of Medicine; S. Kamali, Professor, Division of Rheumatology, Marmara University Faculty of Medicine; G. Hatemi, Associate Professor, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine; T. Kermani, MD, MS, Assistant Clinical Professor, Division of Rheumatology, University of California at Los Angeles; S.L. Mackie, BM, BCh, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; A. Mahr, MD, PhD, Professo

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668221PMC
December 2015

Curry-assisted diagnosis in the rheumatology clinic.

Oxf Med Case Reports 2015 Jun 1;2015(6):297-9. Epub 2015 Jun 1.

Leeds Institute of Rheumatic and Musculoskeletal Medicine , University of Leeds , Leeds , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/omcr/omv040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455788PMC
June 2015

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Am J Hum Genet 2015 Apr 26;96(4):565-80. Epub 2015 Mar 26.

Instituto de Parasitología y Biomedicina "López-Neyra," CSIC, PTS Granada, Granada 18016, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2015.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385191PMC
April 2015

HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis.

Rheumatology (Oxford) 2015 Feb 28;54(2):359-62. Epub 2014 Aug 28.

Department of Rheumatology, Ipswich Hospital NHS Trust, Ipswich, Norwich Medical School, University of East Anglia, Norwich and School of Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/keu321DOI Listing
February 2015

Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

J Rheumatol 2014 May 15;41(5):994-9. Epub 2014 Mar 15.

From the University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; University of California, Geffen School of Medicine, Los Angeles, California, USA; Université de Lorraine, Université Paris Descartes, Nancy; Université Pierre et Marie Curie (UPMC), Paris; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, the Netherlands; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Division of Rheumatic and Musculoskeletal Diseases, University of Leeds, Leeds, UK; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Seattle Rheumatology Associates, Swedish Medical Center Rheumatology Research Division, University of Washington School of Medicine,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.131309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217644PMC
May 2014

Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCA.

Nat Rev Rheumatol 2014 May 18;10(5):264-5. Epub 2014 Mar 18.

Department of Rheumatology, Southend Hospital NHS Trust, Prittlewell Chase, Westcliff-on-Sea, Essex SSO ORY, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2014.38DOI Listing
May 2014

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR.

J Rheumatol 2014 Apr 1;41(4):819-23. Epub 2014 Feb 1.

From UK National Institute for Health Research (NIHR)-Leeds Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Polymyalgia Rheumatica Giant Cell Arteritis (PMRGCA) UK, Bristol; Department of Rheumatology Ashford and St Peter's Hospitals National Health Service (NHS) Foundation Trust, Chertsey, Surrey; Centre for Health and Clinical Research, Faculty of Health and Life Sciences, University of the West of England, Bristol; Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Horizon Pharma Inc., Deerfield, Illinois; SDG LLC, Boston, Massachusetts, USA; Department of Rheumatology, Katholieke Universiteit Leuven, Leuven, Belgium; Academic Rheumatology Unit, University of Bristol, Bristol Royal Infirmary, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.131254DOI Listing
April 2014

Polymyalgia rheumatica.

BMJ 2013 Dec 3;347:f6937. Epub 2013 Dec 3.

National Institute for Health Research-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.f6937DOI Listing
December 2013

Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study.

Ann Rheum Dis 2012 Oct 22;71(10):1640-5. Epub 2012 Mar 22.

NIHR-Leeds Biomedical Research Unit, Leeds Institute of Molecular Medicine, Level 8, Wellcome Trust Brenner Building, St. James's University Hospital, Leeds, LS9 7TF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2011-201003DOI Listing
October 2012

Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors.

Rheumatology (Oxford) 2011 Nov 22;50(11):2014-22. Epub 2011 Aug 22.

NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/ker265DOI Listing
November 2011

Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study.

Rheumatology (Oxford) 2010 Apr 11;49(4):716-22. Epub 2010 Jan 11.

NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kep395DOI Listing
April 2010

Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients.

Clin Vaccine Immunol 2008 Mar 26;15(3):506-12. Epub 2007 Dec 26.

Wellcome Trust Centre for Clinical Tropical Medicine and Department of Paediatrics, Imperial College London, Wright Fleming Institute, United Kingdom.

View Article

Download full-text PDF

Source
http://cvi.asm.org/cgi/doi/10.1128/CVI.00401-07
Publisher Site
http://dx.doi.org/10.1128/CVI.00401-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268261PMC
March 2008

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.

Cancer Res 2007 Sep;67(18):8444-9

Leeds Institute of Molecular Medicine, University of Leeds, Wellcome Trust Brenner Building, St. James's University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-4230DOI Listing
September 2007

Co-stimulatory blockade as therapy for rheumatoid arthritis.

Curr Rheumatol Rep 2005 Oct;7(5):400-6

Academic Unit of Musculoskeletal Disease, University of Leeds, Chapel Allerton Hospital, Leeds, LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-005-0029-4DOI Listing
October 2005